Fisher Wallace
Medical Devices for Mood and Sleep
Overview
Raised: $764,500
Total Commitments ($USD)
Platform
StartEngine
Start Date
09/30/2022
Close Date
02/20/2023
Min. Goal
$9,999
Max. Goal
$1,844,761
Min. Investment
$493
Security Type
Equity - Common
Series
Series A
Funding Type
RegCF
Price Per Share
$8.81
Pre-Money Valuation
$81,567,588
Rolling Commitments ($USD)
Status
Active
Reporting Date
02/02/2023
Days Remaining
18
% of Min. Goal
7,645%
% of Max. Goal
41%
Likelihood of Max
Avg. Daily Raise
$6,116
# of Investors
378
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Location
Brooklyn, New York
Industry
Fitness & Wellness
Tech Sector
Medtech
Distribution Model
B2B/B2C
Margin
High
Capital Intensity
High
Fisher Wallace, with a valuation of $81.6 million, is raising funds on StartEngine. The company manufactures and sells wearable medical devices for mood and sleep disorders, including insomnia, anxiety, and depression. The product of Fisher Wallace Laboratories, Fisher Wallace Stimulator, stimulates the brain to produce serotonin and modulates brainwave activity. The company has generated $30 million in lifetime revenue and has 14,000 prescribers and 100,000 customers. Kelly Roman and Charles Fisher founded Fisher Wallace in August 2019. The current crowdfunding campaign has a minimum target of $9,999.35 and a maximum target of $1,844,761.14. The campaign proceeds will be used to release Version 2 and expand.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$4,230,290 |
$4,250,866 |
|
COGS |
$623,703 |
$970,761 |
|
Tax |
$250 |
$1,597 |
| ||
| ||
|
Net Income |
$-3,262,291 |
$-1,823,732 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$1,929,380 |
$695,749 |
|
Accounts Receivable |
$0 |
$2,302 |
|
Total Assets |
$1,999,403 |
$853,359 |
|
Short-Term Debt |
$471,468 |
$725,122 |
|
Long-Term Debt |
$576,525 |
$620,416 |
|
Total Liabilities |
$1,047,993 |
$1,345,538 |
Financials as of: 09/30/2022
Create a free account today to gain access to KingsCrowd analytics.
Raise History
| Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Fisher Wallace | 02/20/2023 | StartEngine | $81,567,588 | $764,500 | Equity - Common | Active | RegCF |
| Fisher Wallace Laboratories | 09/01/2022 | StartEngine | $81,236,323 | $357,719 | Equity - Common | Funded | RegCF |
| Fisher Wallace Laboratories | 05/27/2022 | StartEngine | $80,048,889 | $1,279,724 | Equity - Common | Funded | RegCF |
| Fisher Wallace Laboratories | 10/26/2021 | StartEngine | $40,000,000 | $5,010,683 | Equity - Common | Funded | RegA+ |
| Fisher Wallace Laboratories | 03/09/2020 | StartEngine | $15,000,000 | $1,056,480 | Equity - Common | Funded | RegCF |
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
